Intrinsic Value of S&P & Nasdaq Contact Us

InflaRx N.V. IFRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • DE • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.00
+65.3%

Over the last 12 months, insiders have made 6 transactions in IFRX stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

IFRX Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-18 Taapken Thomas Chief Financial Officer Unknown 72,000 $1.17 $84.24K
2026-03-18 Ocarroll Derval See Remarks Unknown 21,000 $1.17 $24.57K
2026-03-18 Fulpius Nicolas Director Unknown 45,000 $1.17 $52.65K
2026-03-18 Kubler Mark Director Unknown 30,000 $1.17 $35.1K
2026-03-18 Gibney Anthony S Director Unknown 30,000 $1.17 $35.1K
2026-03-18 Riedemann Niels Chief Executive Officer Unknown 190,500 $1.17 $222.89K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message